Benevolent.ai, a British artificial intelligence (AI) healthcare company, has hired IBM's AI expert Jérôme Pesenti, ex-VP of Watson Core Technology, to head up its technology division. Founded in 2013, benevolent.ai was spun out of the management team working at Proximagen, a pharmaceutical company, who were frustrated with the slow pace of drug discovery. Data from patient databases and scientific papers is constantly expanding, said Ken Mulvany, chairman of benevolent.ai. Some of the information might be true, some of it will be speculative, and some of it will be false. The human brain just doesn't have the capacity to keep up," Mulvany told The Register. Benevolent.ai aims to analyse data and form connections through a knowledge graph, allowing researchers to observe patterns they might have missed. "The data might show that a protein upregulates a particular gene.